Black Diamond Therapeutics, Inc. (BDTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.04
Day's range
$2.18

Black Diamond Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEA MANAGEMENT COMPANY, LLC 08/14/2026 4.45 M $8.23 M   0.00% 7.75%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 4.03 M $7.45 M   -61.87% 7.02%
BLACKROCK, INC. 08/07/2026 3.92 M $7.25 M   253.90% 6.83%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 2.35 M $4.34 M   0.00% 4.09%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.13 M $3.93 M   14.85% 3.70%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.96 M $3.63 M   19.39% 3.42%
DEFILADE CAPITAL MANAGEMENT, L.P. 08/14/2026 1.67 M $3.10 M   100.00% 2.92%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.37 M $2.53 M   4.90% 2.38%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.22 M $2.25 M   127.03% 2.12%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 1.09 M $2.02 M   3.26% 1.91%
AWM INVESTMENT COMPANY, INC. 08/14/2026 1.00 M $1.85 M   90.48% 1.74%
MARSHALL WACE, LLP 08/13/2026 896.60 K $1.66 M   7.21% 1.56%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 791.43 K $1.46 M   9.39% 1.38%
FMR LLC 08/13/2026 643.67 K $1.19 M   3.18% 1.12%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 542.17 K $1.00 M   6.14% 0.95%
STATE STREET CORP 09/22/2026 525.01 K $971.27 K   145.89% 0.92%
BANK OF AMERICA CORP /DE/ 08/14/2026 413.52 K $765.00 K   262.28% 0.72%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 407.07 K $753.09 K   336.87% 0.71%
NORTHERN TRUST CORP 08/13/2026 365.39 K $675.98 K   -21.37% 0.64%
BANK OF NEW YORK MELLON CORP 08/06/2026 318.76 K $589.71 K   68.53% 0.56%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 309.85 K $573.23 K   19.22% 0.54%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 295.17 K $546.07 K   100.00% 0.51%
JANE STREET GROUP, LLC 08/14/2026 289.71 K $535.97 K   205.50% 0.51%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 08/13/2026 288.87 K $534.41 K   58.51% 0.50%
GOLDMAN SACHS GROUP INC 08/14/2026 288.78 K $534.24 K   -57.81% 0.50%
STIFEL FINANCIAL CORP 08/12/2026 281.25 K $520.30 K   0.93% 0.49%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 265.56 K $491.29 K   -68.18% 0.46%
UBS GROUP AG 08/13/2026 265.31 K $490.83 K   -53.03% 0.46%
EMPOWERED FUNDS, LLC 08/17/2026 248.13 K $459.05 K   7.80% 0.43%
MORGAN STANLEY 08/13/2026 231.20 K $427.72 K   160.88% 0.40%
GSA CAPITAL PARTNERS LLP 08/06/2026 220.91 K $409.00 K   30.12% 0.39%
TORONTO DOMINION BANK 08/14/2026 214.00 K $395.90 K   100.00% 0.37%
RITHOLTZ WEALTH MANAGEMENT 08/11/2026 178.48 K $330.19 K   7.95% 0.31%
D. E. SHAW & CO., INC. 08/14/2026 157.34 K $291.08 K   -56.77% 0.27%
INVESCO LTD. 08/14/2026 131.66 K $243.58 K   22.59% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 107.69 K $199.22 K   643.50% 0.19%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 107.69 K $199.22 K   100.00% 0.19%
CANADA PENSION PLAN INVESTMENT BOARD 08/14/2026 103.60 K $191.66 K   -50.99% 0.18%
RB CAPITAL MANAGEMENT, LLC 08/18/2026 100.00 K $185.00 K   185.71% 0.17%
CITADEL ADVISORS LLC 09/02/2026 90.00 K $166.50 K   718.18% 0.16%
AMERICAN CENTURY COMPANIES INC 08/12/2026 81.31 K $150.43 K   -10.69% 0.14%
QUADRATURE CAPITAL LTD 08/07/2026 76.71 K $141.91 K   104.69% 0.13%
NUVEEN, LLC 08/11/2026 64.80 K $119.88 K   100.00% 0.11%
RAYMOND JAMES FINANCIAL INC 08/14/2026 62.24 K $115.14 K   340.91% 0.11%
CITADEL ADVISORS LLC 09/02/2026 61.00 K $112.85 K   -32.89% 0.11%
GRAHAM CAPITAL MANAGEMENT, L.P. 08/14/2026 54.23 K $100.33 K   -68.27% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 52.90 K $97.87 K   96.65% 0.09%
ASTER CAPITAL MANAGEMENT (DIFC) LTD 08/13/2026 49.17 K $121.94 K   100.00% 0.09%
DEUTSCHE BANK AG\ 08/07/2026 46.04 K $85.17 K   100.00% 0.08%
XTX TOPCO LTD 08/14/2026 44.30 K $81.96 K   -16.16% 0.08%

Black Diamond Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 150 institutional investors and hedge funds held shares of Black Diamond Therapeutics Inc. The most heavily invested institutionals were:

NEA Management Company, LLC: 4.45 M

T. Rowe Price Investment Management, Inc.: 4.03 M

BlackRock, Inc.: 3.92 M

ACADIAN ASSET MANAGEMENT LLC: 2.35 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.13 M

RENAISSANCE TECHNOLOGIES LLC: 1.96 M

61.37% of Black Diamond Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 42.51 M shares in the last 24 months. This purchase volume represents approximately $92.66 M in transactions.